@article{TCR10092,
author = {Shixu Lyu and Lechi Ye and Tao Li and Fan Yang and Xuting Zhi},
title = {Liver resection of metastases for colorectal cancer, gastric cancer and breast cancer: two hospital experiences},
journal = {Translational Cancer Research},
volume = {5},
number = {5},
year = {2016},
keywords = {},
abstract = {Background: Surgical resection of liver metastases from colorectal cancer (CRC) is considered to have the curative potential in selected patients. In the field of gastric cancer (GC) and breast cancer (BC), opinion differs from one another.
Methods: We analyzed the outcomes for patients who underwent liver resection for CRC liver metastases (CRLM), gastric cancer liver metastases (GLM) and breast cancer liver metastases (BLM) in two hospitals to identify the survival and prognostic factors.
Results: From January 2002 to January 2015, a total of 181 patients were enrolled in the study. Primary tumor sites included 122 CRC, 38 GC and 21 BC. The overall 5-year survival rate was 39.2% in all the 181 patients, and that was 42.5%, 25.1%, 52.4% in CRLM, GLM and BLM patients, respectively. The 5-year survival rate was 45.7% and 33.9% (P=0.03) in patients with disease-free survival (DFS) ≥18 and },
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/10092}
}